Botulinum toxin A: a new treatment option for multiple-sclerosis-related bladder overactivity?
Bahman Jabbari
Correspondence Department of Neurology, Yale University School of Medicine, LCI 708, 15 York Street, New Haven, CT 06520, USA
Email bj46@email.med.yale.edu
This article has no abstract so we have provided the first paragraph of the full text.
An overactive bladder with the cardinal symptoms of urge micturition, increased frequency and incontinence is an important source of disability in MS. The most common finding in cystomanometric studies of patients with MS who have an overactive bladder is detrusor overactivity, which is observed in approximately 65% of patients.1
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.